<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.jnanobiotechnology.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Nanobiotechnology - Latest Articles</title>
        <link>http://www.jnanobiotechnology.com</link>
        <description>The latest research articles published by Journal of Nanobiotechnology</description>
        <dc:date>2012-05-06T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/19" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/18" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/17" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/16" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/15" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/14" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/13" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/12" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/11" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/10/1/10" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/19">
        <title>Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guerin</title>
        <description>Background:
Diseases such as tuberculosis (TB) have always had a large impact on human health. Bacillus Calmette-Guerin (BCG) is used as a surrogate for TB during the development of anti-TB drugs. Nanoparticles (NPs) have attracted great interest in drug development. The purpose of this study was to examine the potential of NPs as anti-TB compounds by studying the interaction mechanism between NPs and bacteria.
Results:
We investigated effects of gold and silver NPs on BCG and Escherichia coli. Experimentally, particle size and shape were characterized using transmission electron microscopy (TEM). Different concentrations of NPs were applied in bacterial culture. The growth of E. coli was monitored through colony forming units (CFU). The mechanism of interaction between NPs and bacteria was analyzed through bacterial thin sections followed by TEM and scanning electron microscopy. Antibacterial effects on BCG were observed by recording fluorescent protein expression levels.
Conclusions:
The results suggest NPs have potential applications as anti-TB compounds. The antibacterial effects and mechanism of action for NPs were dependent upon composition and surface modifications.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/19</link>
                <dc:creator>Yan Zhou</dc:creator>
                <dc:creator>Ying Kong</dc:creator>
                <dc:creator>Subrata Kundu</dc:creator>
                <dc:creator>Jeffrey Cirillo</dc:creator>
                <dc:creator>Hong Liang</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:19</dc:source>
        <dc:date>2012-05-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-19</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-19-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2012-05-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/18">
        <title>Biotemplating rod-like viruses for the synthesis of copper nanorods and nanowires</title>
        <description>Background:
In the past decade spherical and rod-like viruses have been used for the design and synthesis of new kind of nanomaterials with unique chemical positioning, shape, and dimensions in the nanosize regime.  Wild type and genetic engineered viruses have served as excellent templates and scaffolds for the synthesis of hybrid materials with unique properties imparted by the incorporation of biological and organic moieties and inorganic nanoparticles. Although great advances have been accomplished, still there is a broad interest in developing reaction conditions suitable for biological templates while not limiting the material property of the product.
Results:
We demonstrate the controlled synthesis of copper nanorods and nanowires by electroless deposition of Cu on three types of Pd-activated rod-like viruses. Our aqueous solution-based method is scalable and versatile for biotemplating, resulting in Cu-nanorods 24-46 nm in diameter as measured by transmission electron microscopy. Cu2+ was chemically reduced onto Pd activated tobacco mosaic virus, fd and M13 bacteriophages to produce a complete and uniform Cu coverage. The Cu coating was a combination of Cu0 and Cu2O as determined by X- ray photoelectron spectroscopy analysis. A capping agent, synthesized in house, was used to disperse Cu-nanorods in aqueous and organic solvents. Likewise, reactions were developed to produce Cu-nanowires by metallization of polyaniline-coated tobacco mosaic virus.
Conclusions:
Synthesis conditions described in the current work are scalable and amenable for biological templates. The synthesized structures preserve the dimensions and shape of the rod-like viruses utilized during the study. The current work opens the possibility of generating a variety of nanorods and nanowires of different lengths ranging from 300 nm to micron sizes. Such biological-based materials may find ample use in nanoelectronics, sensing, and cancer therapy.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/18</link>
                <dc:creator>Jing Zhou</dc:creator>
                <dc:creator>Carissa Soto</dc:creator>
                <dc:creator>Mu-San Chen</dc:creator>
                <dc:creator>Michael Bruckman</dc:creator>
                <dc:creator>Martin Moore</dc:creator>
                <dc:creator>Edward Barry</dc:creator>
                <dc:creator>Banahalli Ratna</dc:creator>
                <dc:creator>Pehr Pehrsson</dc:creator>
                <dc:creator>Bradley Spies</dc:creator>
                <dc:creator>Tammie Confer</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:18</dc:source>
        <dc:date>2012-05-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-18</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-18-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>18</prism:startingPage>
        <prism:publicationDate>2012-05-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/17">
        <title>Gnidia glauca flower extract mediated synthesis of gold nanoparticles and evaluation of its chemocatalytic potential</title>
        <description>Background:
Novel approaches for synthesis of gold nanoparticles (AuNPs) is of utmost importance owing to its immense application in diverse fields including catalysis, optics, medical diagnostics and therapeutics. This is the first report on synthesis of gold nanoparticles using Gnidia glauca flower extract (GGFE), its detailed characterization and evaluation of its chemocatalytic potential.
Results:
Synthesis of AuNPs using GGFE was monitored by UV-Vis spectroscopy and was found to be rapid that completed within 20 min. The concentration of gold chloride and temperature was optimized to be 0.7 mM and 50 degreesC respectively. Bioreduced nanoparticles varied in morphology from nanotriangles to nanohexagons majority being spherical. AuNPs were characterized employing transmission electron microscopy, high resolution transmission electron microscopy. Confirmation of elemental gold was carried out by elemental mapping in scanning transmission electron microscopic mode, energy dispersive spectroscopy and X-ray diffraction studies.  Spherical particle of size ~10 nm were found in majority. However, particles of larger dimensions were in range between 50-150 nm. The bioreduced AuNPs exhibited remarkable catalytic properties in a reduction reaction of 4-nitrophenol to 4-aminophenol by NaBH4 in aqueous phase.
Conclusion:
The elaborate experimental evidences support that GGFE can provide a novel environmentally benign rapid route for synthesis of AuNPs that can be applied for various purposes. This is the first report of chemocatalytic potential of biogenic gold nanoparticles synthesized using GGFE.KeywordsGnidia glauca, gold nanoparticles, UV-Visible spectroscopy, transmission electron microscopy, high resolution transmission electron microscopy, elemental mapping, energy dispersive spectroscopy, dynamic light scattering, X-ray diffraction, chemocatalysis.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/17</link>
                <dc:creator>Sougata Ghosh</dc:creator>
                <dc:creator>Sumersing Patil</dc:creator>
                <dc:creator>Mehul Ahire</dc:creator>
                <dc:creator>Rohini Kitture</dc:creator>
                <dc:creator>Deepanjali Gurav</dc:creator>
                <dc:creator>Amit Jabgunde</dc:creator>
                <dc:creator>Sangeeta Kale</dc:creator>
                <dc:creator>Karishma Pardesi</dc:creator>
                <dc:creator>Vaishali Shinde</dc:creator>
                <dc:creator>Jayesh Bellare</dc:creator>
                <dc:creator>Dilip Dhavale</dc:creator>
                <dc:creator>Balu Chopade</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:17</dc:source>
        <dc:date>2012-05-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-17</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-17-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2012-05-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/16">
        <title>Genotoxicity and molecular response of silver nanoparticle (NP)-based hydrogel</title>
        <description>Due to silver-nanoparticles (NPs) possess a special antibacterial activity, they were used most commonly in medical products and devices, food storage materials, cosmetics, various health care products, and industrial products. In medical applications of silver-NPs, various silver-based medical devices have become available for clinical use, such as silver-based dressings and silver-based hydrogel, and so on. In this study, the genotoxicity of silver nanoparticle-based hydrogel (silver-NP/Gel) was assayed by using cytokinesis-block micronucleus (CBMN), and the molecular response was demonstrated by using DNA microarray and GO pathway analysis. The results showed that silver-NP/Gel induced the formation of micronuclei in HeLa cells. Global gene expression analysis showed that more than thousands of differential expressed genes were up- and down-regulated at 48 h of silver-NP/Gel exposure. Further GO pathway analysis suggested that fourteen theoretical activating signaling pathways were attributed to up-regulated genes and three signal pathways were attributed to down-regulated genes. It was further discussed that the changes to DNA damage, apoptosis and mitosis pathway were closely related to silver-NP-induced cytotoxicity and chromosome damage. The down-regulation of CDC14A via mitosis pathway suggested that it may play a role in the potential genotoxicity induced by silver-NP. The balance between anti-ROS response and DNA damage, chromosome unstable and mitosis inhibition play an important role on silver-NP induced toxicity. The inflammatory factors likely were particularly involved in silver-NP/Gel complex-induced toxic effects via JAK-STAT signal transduction pathway and immune response pathway. These biological responses eventually decide the future of the cells, survival or apoptosis.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/16</link>
                <dc:creator>Liming Xu</dc:creator>
                <dc:creator>Xuefei Li</dc:creator>
                <dc:creator>Taro Takemura</dc:creator>
                <dc:creator>Nobutaka Hanagata</dc:creator>
                <dc:creator>Gang Wu</dc:creator>
                <dc:creator>Laisheng Chou</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:16</dc:source>
        <dc:date>2012-05-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-16</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-16-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2012-05-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/15">
        <title>The cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism</title>
        <description>Background:
Iron oxide magnetic nanoparticles (MNP&apos;s) have an increasing number of biomedical applications. As such in vitro characterisation is essential to ensure the bio-safety of these particles. Little is known on the cellular interaction or effect on membrane integrity upon exposure to these MNPs. Here we synthesised Fe3O4 and surface coated with poly(ethylenimine) (PEI) and poly(ethylene glycol) (PEG) to achieve particles of varying surface positive charges and used them as model MNP&apos;s to evaluate the relative utility and limitations of cellular assays commonly applied for nanotoxicity assessment. An alternative approach, atomic force microscopy (AFM), was explored for the analysis of membrane structure and cell morphology upon interacting with the MNPs. The particles were tested in vitro on human SH-SY5Y, MCF-7 and U937 cell lines for reactive oxygen species (ROS) production and lipid peroxidation (LPO), LDH leakage and their overall cytotoxic effect. These results were compared with AFM topography imaging carried out on fixed cell lines.
Results:
Successful particle synthesis and coating were characterised using FTIR, PCS, TEM and ICP. The particle size from TEM was 30 nm (16.9 mV) which increased to 40 nm (+55.6 mV) upon coating with PEI and subsequently 50 nm (+31.2 mV) with PEG coating. Both particles showed excellent stability not only at neutral pH but also in acidic environment of pH 4.6 in the presence of sodium citrate. The higher surface charge MNP-PEI resulted in increased cytotoxic effect and ROS production on all cell lines compared with the MNP-PEI-PEG. In general the effect on the cell membrane integrity was observed only in SH-SY5Y and MCF-7 cells by MNP-PEI determined by LDH leakage and LPO production. AFM topography images showed consistently that both the highly charged MNP-PEI and the less charged MNP-PEI-PEG caused cell morphology changes possibly due to membrane disruption and cytoskeleton remodelling.
Conclusions:
Our findings indicate that common in vitro cell endpoint assays do not give detailed and complete information on cellular state and it is essential to explore novel approaches and carry out more in-depth studies to elucidate cellular response mechanism to magnetic nanoparticles.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/15</link>
                <dc:creator>Clare Hoskins</dc:creator>
                <dc:creator>Alfred Cuschieri</dc:creator>
                <dc:creator>Lijun Wang</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:15</dc:source>
        <dc:date>2012-04-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-15</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-15-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2012-04-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/14">
        <title>Toxicity of various silver nanoparticles compared to silver ions in Daphnia magna</title>
        <description>Background:
To better understand the potential ecotoxicological impacts of silver nanoparticles released into freshwater environments, the Daphnia magna 48-hour immobilization test was used.
Methods:
The toxicities of silver nitrate, two types of colloidal silver nanoparticles, and a suspension of silver nanoparticles were assessed and compared using standard OECD guidelines. Also, the swimming behavior and visible uptake of the nanoparticles by Daphnia were investigated and compared. The particle suspension and colloids used in the toxicity tests were well-characterized.
Results:
The results obtained from the exposure studies showed that the toxicity of all the silver species tested was dose and composition dependent. Plus, the silver nanoparticle powders subsequently suspended in the exposure water were much less toxic than the previously prepared silver nanoparticle colloids, whereas the colloidal silver nanoparticles and AgNO3 were almost similar in terms of mortality. The silver nanoparticles were ingested by the Daphnia and accumulated under the carapace, on the external body surface, and connected to the appendages. All the silver species in this study caused abnormal swimming by the D. magna.
Conclusion:
According to the present results, silver nanoparticles should be classified according to GHS (Globally Harmonized System of classification and labeling of chemicals) as &quot;category acute 1&quot; to Daphnia neonates, suggesting that the release of nanosilver into the environment should be carefully considered.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/14</link>
                <dc:creator>Saba Asghari</dc:creator>
                <dc:creator>Seyed Ali Johari</dc:creator>
                <dc:creator>Ji Hyun Lee</dc:creator>
                <dc:creator>Yong Seok Kim</dc:creator>
                <dc:creator>Yong Bae Jeon</dc:creator>
                <dc:creator>Hyun Jung Choi</dc:creator>
                <dc:creator>Min Chaul Moon</dc:creator>
                <dc:creator>Il Je Yu</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:14</dc:source>
        <dc:date>2012-04-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-14</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-14-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2012-04-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/13">
        <title>A Tetravalent Dengue Nanoparticle stimulates antibody production in mice</title>
        <description>Background:
Dengue is a major public health problem worldwide, especially in the tropical and subtropical regions of the world. Infection with a single Dengue virus (DENV) serotype causes a mild, self-limiting febrile illness called dengue fever. However, a subset of patients experiencing secondary infection with a different serotype progresses to the severe form of the disease, dengue hemorrhagic fever/dengue shock syndrome. Currently, there are no licensed vaccines or antiviral drugs to prevent or treat dengue infections. Biodegradable nanoparticles coated with proteins represent a promising method for in vivo delivery of vaccines.FindingsHere, we used a murine model to evaluate the IgG production after administration of inactivated DENV corresponding to all four serotypes adsorbed to bovine serum albumin nanoparticles. This formulation induced a production of anti-DENV IgG antibodies (p &lt; 0.001). However, plaque reduction neutralization assays with the four DENV serotypes revealed that these antibodies have no neutralizing activity in the dilutions tested.
Conclusions:
Our results show that while the nanoparticle system induces humoral responses against DENV, further investigation with different DENV antigens will be required to improve immunogenicity, epitope specicity, and functional activity to make this platform a viable option for DENV vaccines.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/13</link>
                <dc:creator>Elisangela Silva</dc:creator>
                <dc:creator>Mariana Orsi</dc:creator>
                <dc:creator>Angela Andrade</dc:creator>
                <dc:creator>Rosana Domingues</dc:creator>
                <dc:creator>Breno Silva</dc:creator>
                <dc:creator>Helena de Araujo</dc:creator>
                <dc:creator>Paulo Pimenta</dc:creator>
                <dc:creator>Michael Diamond</dc:creator>
                <dc:creator>Eliseu Rocha</dc:creator>
                <dc:creator>Erna Kroon</dc:creator>
                <dc:creator>Luiz Malaquias</dc:creator>
                <dc:creator>Luiz Coelho</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:13</dc:source>
        <dc:date>2012-03-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-13</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-13-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2012-03-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/12">
        <title>Microarray-based method for screening of immunogenic proteins from bacteria</title>
        <description>Background:
Detection of immunogenic proteins remains an important task for life sciences as it nourishes the understanding of pathogenicity, illuminates new potential vaccine candidates and broadens the spectrum of biomarkers applicable in diagnostic tools. Traditionally, immunoscreenings of expression libraries via polyclonal sera on nitrocellulose membranes or screenings of whole proteome lysates in 2-D gel electrophoresis are performed. However, these methods feature some rather inconvenient disadvantages. Screening of expression libraries to expose novel antigens from bacteria often lead to an abundance of false positive signals owing to the high cross reactivity of polyclonal antibodies towards the proteins of the expression host. A method is presented that overcomes many disadvantages of the old procedures.
Results:
Four proteins that have previously been described as immunogenic have successfully been assessed immunogenic abilities with our method. One protein with no known immunogenic behaviour before suggested potential immunogenicity.We incorporated a fusion tag prior to our genes of interest and attached the expressed fusion proteins covalently on microarrays. This enhances the specific binding of the proteins compared to nitrocellulose. Thus, it helps to reduce the number of false positives significantly. It enables us to screen for immunogenic proteins in a shorter time, with more samples and statistical reliability. We validated our method by employing several known genes from Campylobacter jejuni NCTC 11168.
Conclusions:
The method presented offers a new approach for screening of bacterial expression libraries to illuminate novel proteins with immunogenic features. It could provide a powerful and attractive alternative to existing methods and help to detect and identify vaccine candidates, biomarkers and potential virulence-associated factors with immunogenic behaviour furthering the knowledge of virulence and pathogenicity of studied bacteria.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/12</link>
                <dc:creator>Sebastian Hoppe</dc:creator>
                <dc:creator>Frank Bier</dc:creator>
                <dc:creator>Markus von Nickisch-Rosenegk</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:12</dc:source>
        <dc:date>2012-03-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-12</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-12-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2012-03-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/11">
        <title>Pulsed ultrasound associated with gold nanoparticle gel reduces oxidative stress parameters and expression of proinflammatory molecules in an animal model of muscle injury</title>
        <description>Background:
Nanogold has been investigated in a wide variety of biomedical applications because of the anti-inflammatory properties. The purpose of this study was to evaluate the effects of TPU (Therapeutic Pulsed Ultrasound) with gold nanoparticles (GNP) on oxidative stress parameters and the expression of pro-inflammatory molecules after traumatic muscle injury.Materials and methodsAnimals were divided in nine groups: sham (uninjured muscle); muscle injury without treatment; muscle injury + DMSO; muscle injury + GNP; muscle injury + DMSO + GNP; muscle injury + TPU; muscle injury + TPU + DMSO; muscle injury + TPU + GNP; muscle injury + TPU + DMSO + GNP. The ROS production was determined by concentration of superoxide anion, modulation of antioxidant defenses was determined by the activity of superoxide dismutase, catalase and glutathione peroxidase enzymes, oxidative damage determined by formation of thiobarbituric acid-reactive substance and protein carbonyls. The levels of interleukin-1&#946; (IL-1&#946;) and tumor necrosis factor-&#945; (TNF-&#945;) were measured as inflammatory parameters.
Results:
Compared to muscle injury without treatment group, the muscle injury + TPU + DMSO + GNP gel group promoted a significant decrease in superoxide anion production and lipid peroxidation levels (p &lt; 0.050). It also showed a significant decrease in TNF-&#945; and IL-1&#946; levels (p &lt; 0.050) when compared to muscle injury without treatment group.
Conclusions:
Our results suggest that TPU + DMSO + GNP gel presents beneficial effects on the muscular healing process, inducing a reduction in the production of ROS and also the expression of pro-inflammatory molecules.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/11</link>
                <dc:creator>Eduardo VIctor</dc:creator>
                <dc:creator>Paulo Silveira</dc:creator>
                <dc:creator>Jonathann Possato</dc:creator>
                <dc:creator>Guilherme da Rosa</dc:creator>
                <dc:creator>Uillian Munari</dc:creator>
                <dc:creator>Claudio de Souza</dc:creator>
                <dc:creator>Ricardo Pinho</dc:creator>
                <dc:creator>Luciano da Silva</dc:creator>
                <dc:creator>Emilio Streck</dc:creator>
                <dc:creator>Marcos Paula</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:11</dc:source>
        <dc:date>2012-03-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-11</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-11-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2012-03-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/10/1/10">
        <title>Gold nanoparticles as high-resolution X-ray imaging contrast agents for the analysis of tumor-related micro-vasculature</title>
        <description>Background:
Angiogenesis is widely investigated in conjunction with cancer development, in particular because of the possibility of early stage detection and of new therapeutic strategies. However, such studies are negatively affected by the limitations of imaging techniques in the detection of microscopic blood vessels (diameter 3-5 &#956;m) grown under angiogenic stress. We report that synchrotron-based X-ray imaging techniques with very high spatial resolution can overcome this obstacle, provided that suitable contrast agents are used.
Results:
We tested different contrast agents based on gold nanoparticles (AuNPs) for the detection of cancer-related angiogenesis by synchrotron microradiology, microtomography and high resolution X-ray microscopy. Among them only bare-AuNPs in conjunction with heparin injection provided sufficient contrast to allow in vivo detection of small capillary species (the smallest measured lumen diameters were 3-5 &#956;m). The detected vessel density was 3-7 times higher than with other nanoparticles. We also found that bare-AuNPs with heparin allows detecting symptoms of local extravascular nanoparticle diffusion in tumor areas where capillary leakage appeared.
Conclusions:
Although high-Z AuNPs are natural candidates as radiology contrast agents, their success is not guaranteed, in particular when targeting very small blood vessels in tumor-related angiography. We found that AuNPs injected with heparin produced the contrast level needed to reveal--for the first time by X-ray imaging--tumor microvessels with 3-5 &#956;m diameter as well as extravascular diffusion due to basal membrane defenestration. These results open the interesting possibility of functional imaging of the tumor microvasculature, of its development and organization, as well as of the effects of anti-angiogenic drugs.</description>
        <link>http://www.jnanobiotechnology.com/content/10/1/10</link>
                <dc:creator>Chia-Chi Chien</dc:creator>
                <dc:creator>H. Chen</dc:creator>
                <dc:creator>S. Lai</dc:creator>
                <dc:creator>Kang-Chao Wu</dc:creator>
                <dc:creator>Xiaoqing Cai</dc:creator>
                <dc:creator>Y. Hwu</dc:creator>
                <dc:creator>Cyril Petibois</dc:creator>
                <dc:creator>Y. s. Chu</dc:creator>
                <dc:creator>G. Margaritondo</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2012, null:10</dc:source>
        <dc:date>2012-03-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-10-10</dc:identifier>
                                <prism:require>/content/figures/1477-3155-10-10-toc.gif</prism:require>
                <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2012-03-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

